Melissa M. Dimilta
Partner, Trademark Agent

Melissa Dimilta is an experienced intellectual property litigator and strategist. Melissa advises clients on all types of intellectual property including, patents, trademarks, copyrights and industrial design, and on life science regulatory issues.
Overview
Client Work
Amgen Canada Inc. in the first motion to delist a patent under the amended Patented Medicines (Notice of Compliance Regulations) (Bayer Inc v Amgen Canada Inc, 2024 FC 1849)
Amgen Canada Inc. in a judicial review application brought by Bayer Inc. (Bayer Inc. v Amgen Canada Inc., 2025 FC 107 aff'd 2025 FCA 142)
Amgen Canada Inc. on a motion to compel samples brought by Bayer Inc. and Regeneron Pharmaceuticals Inc. (2025 FC 264)
Amgen Canada Inc. in five different actions brought by Bayer Inc. and Regeneron Pharmaceuticals Inc. under the Patented Medicines (Notice of Compliance Regulations) related to the drug aflibercept
Alexa Translations in its trademark infringement action against Amazon.com
Biosteel Inc. and D.C. Holdings Ltd. on a motion seeking an interlocutory injunction based on a claim for passing off against Cizzle Brands Ltd. and Cizzle Brands Inc.
Recognitions & Awards
The Legal 500 Canada
Managing IP
WTR 1000 The World's Leading Trademark Professionals
Related Services
Education & Bar Admissions
Education
- University of Toronto, BSc (Hons), 2007
 - University of Windsor, JD, 2011
 
Bar Admissions
- Ontario, 2012
 




